U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07729137) titled 'Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction' on July 22.
Brief Summary: This study will evaluate the safety and effectiveness of a single injection of EO2002 at one of two dose levels (150,000 or 500,000 magnetic human corneal endothelial cells [mHCECs]), compared with a placebo injection, in participants with corneal edema caused by corneal endothelial dysfunction.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Corneal Edema
Fuchs
Fuchs Dystrophy
Fuchs' Endothelial Dystrophy
Endothelial Corneal Dystrophy
Corneal Endothelial Decompensation
Corneal Endothelial C...